Skip to main content

Information about cancer and COVID-19 - Treatment

Australia & New Zealand

National COVID-19 Clinical Evidence Taskforce
Caring for people with COVID-19
Date: 01-Jul-2021
Audience: Clinicians
Purpose: New living guidelines that will provide continuously-updated, evidence-based guidance to clinicians treating people with confirmed or suspected COVID-19 infections across primary, acute and critical care settings.

Youth Cancer Service/Canteen
COVID-19 Resources for cancer care professionals
Date: 18-Aug-2020
Audience: Health professionals
Purpose: Resources for health professionals who work in cancer care and their patients to deal with COVID-19.

The Haematology Society of Australia and New Zealand (HSANZ)
Australian and New Zealand consensus statement on the management of lymphoma, chronic lymphocytic leukaemia and myeloma during the COVID‐19 pandemic
Date: 15-May-2020
Audience: Clinicians
Purpose: Guidance to clinicians for patients with haematological malignancies during the COVID‐19 pandemic.

Australian and New Zealand Children’s Haematology/Oncology Group (ANZCHOG)
Updated advice for paediatric oncology and BMT patients during the COVID-19 pandemic
Date: 08-May-2020
Audience: Australian and New Zealand paediatric oncology community
Purpose: Guidance for paediatric oncology and BMT patients during the COVID-19 pandemic.

Australian and New Zealand Children’s Haematology/Oncology Group (ANZCHOG)
COVID-19 Guidance for children and young people undergoing cancer treatment
Date: 25-Mar-2020
Audience: Australian and New Zealand paediatric oncology community
Purpose: COVID-19 Guidance and FAQ for children and young people undergoing cancer treatment.

Queensland Health
COVID-19 Cancer Guidelines
Date: 09-Apr-2020
Audience: Clinicians
Purpose: Guidance to support clinicians in treating cancer patients during the COVID-19 pandemic.

Victorian COVID-19 Cancer Network (VCCN)
Victorian COVID-19 cancer network
Date: 29-Mar-2020
Audience: Health professionals
Purpose: Provide support and advice to enable clinicians and health care services to deliver best possible care for patients with cancer during the COVID-19 pandemic.

Weinkove et al, Medical Journal of Australia
Managing haematology and oncology patients during the COVID-19 pandemic: interim consensus guidance
Date: 20-Mar-2020
Audience: Health professionals including medical oncologists and radiation oncologists
Purpose: Summarises the clinical presentation and diagnosis of COVID-19 disease, provides factors to consider when managing patients with cancer, and discusses risk factors for severe COVID-19 disease.

UK

National Health Service (NHS) England and NHS Improvement coronavirus
NHS England interim treatment options during the COVID-19 pandemic
Date: 30-Jun-2021
Audience: Health professionals including medical oncologists and radiation oncologists
Purpose: Interim treatment options in the management of cancer during the COVID-19 pandemic.

National Health Service (NHS) England and NHS Improvement coronavirus
Clinical guide for the management of non-coronavirus patients requiring acute treatment: Cancer
Date: 01-Apr-2021
Audience: Health professionals including medical oncologists and radiation oncologist
Purpose: Multidisciplinary clinical guide for the management of noncoronavirus patients with cancer.

National Institute for Health and Care Excellence (NICE)
COVID‐19 rapid guideline on haematopoietic stem cell transplantation: development, implementation and impact
Date: 10-Feb-2021
Audience: Haematologists and other health professionals
Purpose: Guidance on haematopoietic stem cell transplantation during the COVID-19 pandemic.

BASO – The Association for Cancer Surgery
Pragmatic management of breast cancer during COVID-19
Date: 25-Mar-2020
Audience: Health professionals including surgical oncologists
Purpose: Guidance for the management of breast cancer patients during the COVID-19 pandemic.

Canada

Canadian Urologic Oncology Group and the Canadian Urological Association
Framework for managing prostate cancer during the COVID-19 pandemic: Recommendations from the Canadian Urologic Oncology Group and the Canadian Urological Association
Date: 28-Apr-2020
Audience: Clinicians
Purpose: Multidisciplinary framework focused on prostate cancer management during the COVID-19 pandemic.

Cancer Care Ontario
COVID-19 Supplemental Clinical Guidance for Patients with Cancer
Date: 29-Mar-2020
Audience: Clinicians
Purpose: Guidance specific to clinical care during the COVID-19 pandemic.

Cancer Care Ontario
Pandemic Planning Clinical Guideline for Patients with Cancer
Date: 10-Mar-2020
Audience: Multidisciplinary health professionals
Purpose: Recommendations for a systematic approach in determining priority for consultation and treatment of patients with cancer in Ontario during the time of a pandemic.

USA

Oncology Nursing Society (ONS)
ONS Information regarding the coronavirus (COVID-19)
Date: 25-Jun-2021
Audience: Oncology nurses
Purpose: Information for oncology nurses around the novel coronavirus, personal protective equipment (PPE) and safety information, resources for patient care and support, nursing and professional practice information, and details on advocacy efforts during the pandemic.

National Comprehensive Cancer Network (NCCN)
Management of COVID-19 infection in patients with cancer
Date: 11-Mar-2021
Audience: Health professionals
Purpose: Guidance for the care of cancer patients during the COVID-19 pandemic.

National Comprehensive Cancer Network (NCCN)
Management of prostate cancer during the COVID-19 pandemic
Date: 01-Apr-2020
Audience: Health professionals
Purpose: Guidance is intended to provide a framework to think about how to manage prostate cancer patients.

National Comprehensive Cancer Network (NCCN)
Advisory statement for non-melanoma skin cancer care during the COVID-19 pandemic
Date: 30-Mar-2020
Audience: Health professionals
Purpose: Guidance for Non-Melanoma Skin Cancer Management during COVID-19 pandemic.

National Comprehensive Cancer Network (NCCN)
Short-term recommendations for cutaneous melanoma management during COVID-19 pandemic
Date: 25-Mar-2020
Audience: Health professionals
Purpose: Short-term guidance for Cutaneous Melanoma Management during COVID-19 pandemic.

American Society of Clinical Oncology (ASCO)
ASCO Coronavirus Resources
Date: 01-Feb-2021
Audience: Oncology community
Purpose: Resources to support clinicians and the cancer care delivery team to help ensure that individuals with cancer receive high-quality care, including patient care information, provider and practice information.

American Society of Clinical Oncology (ASCO)
American Society of Clinical Oncology Road to Recovery Report: Learning From the COVID-19 Experience to Improve Clinical Research and Cancer Care
Date: 08-Dec-2020
Audience: Research sponsors, health systems, and other stakeholders in the healthcare system
Purpose: Recommendations for modifying prepandemic policies and practices to improve patient access to high-quality cancer care and opportunities to participate in research.

Europe

The European Academy of Dermatology and Venereology Melanoma Task Force
Position statement of the EADV Melanoma Task Force on recommendations for the management of cutaneous melanoma patients during COVID‐19
Date: 29-Mar-21
Audience: Health professionals
Purpose: Consensus‐based recommendations on how to address the main challenges in management of patients with cutaneous melanoma during the COVID‐19 pandemic

European Society for Blood and Marrow Transplantation
Management of patients with acute leukemia during the COVID-19 outbreak: Practical guidelines from the acute leukemia working party of the European Society for Blood and Marrow Transplantation
Date: 11-Jun-20
Audience: Haematologists
Purpose: Recommendations to help with the management of acute leukemia patients during the COVID-19 pandemic.

European Myeloma Network (EMN)
Management of patients with multiple myeloma in the era of COVID-19 pandemic: a consensus paper from the European Myeloma Network (EMN)
Date: 22-May-2020
Audience: Health professionals
Purpose: Guidance on the management of multiple myeloma patients during the COVID-19 pandemic.

A French intergroup clinical point of view (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR)
COVID-19 epidemic: Proposed alternatives in the management of digestive cancers: A French intergroup clinical point of view (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR)
Date: 14-May-2020
Audience: Gastroenterologists
Purpose: Guidance on diagnostic procedures, therapies and care strategies for patients treated for digestive cancer during the COVID-19 epidemic.

French High Council for Public Health (HSCP) 
The official French guidelines to protect patients with cancer against SARS-CoV-2 infection
Date: 25-Mar-2020
Audience: Oncology departments
Purpose: Guidelines to protect patients with cancer against infection, and cancer management in patients with and without COVID-19.

Asia

Hong Kong Urological Association and Hong Kong Society of Uro-oncology
Prostate cancer management in the era of COVID‐19: Recommendations from the Hong Kong Urological Association and Hong Kong Society of Uro‐oncology
Date: 15-Apr-2021
Audience: Urologists and oncologists
Purpose: Recommendations on the management of prostate cancer during the COVID-19 pandemic.

Korean Cancer Association
Guidelines for cancer care during the COVID-19 pandemic in South Korea
Audience: Oncologists and health professionals
Purpose: Clinical practice guidelines for oncologists on how to best manage cancer patients during the COVID-19 pandemic.

Asia and Oceania Federation of Obstetrics and Gynecology oncology committee opinion
Guidelines on the management of gynecological cancers during the COVID-19 pandemic
Audience: Gynaecologists and health professionals
Purpose: Opinion statement on the management of gynecological cancer patients during the COVID‐19 pandemic.

Japan Association of Molecular Targeted Therapy for HCC
Treatment of Hepatocellular Carcinoma (HCC) during the COVID‐19 Outbreak: The Working Group Report of JAMTT‐HCC
Date: 24-Jun-2020
Audience: Health professionals
Purpose: Guidance for the management of hepatocellular carcinoma during the COVID-19 pandemic.

Indian Society of Neuro-Oncology (ISNO)
ISNO position statement on treatment guidance in neuro-oncology during pandemics
Date: 26-Aug-2020
Audience: Health professionals
Purpose: Recommendations to guide the care of neuro-oncology patients during the COVID-19 pandemic.

South America

São Paulo Clínicas Liver Cancer Group
Management of Hepatocellular Carcinoma during the COVID-19 Pandemic - São Paulo Clínicas Liver Cancer Group Multidisciplinary Consensus Statement
Date: 26-Oct-2020
Audience: Oncologists
Purpose: Guidance to standardize the management of HCC patients during the COVID-19 pandemic.

Brazilian Society of Surgical Oncology
Perioperative cancer care in the context of limited resources during the COVID-19 pandemic: Brazilian Society of Surgical Oncology recommendations
Date: 26-Sep-2020
Audience: Surgical oncologists
Purpose: A protocol for safe and rational use of resources to reduce the risk of surgical cancer patients being operated on during the COVID-19 pandemic, in the context of areas with limited resources.

Brazilian Thoracic Oncology Group
Lung Cancer and the COVID-19 pandemic: Recommendations from the Brazilian Thoracic Oncology Group
Date: 22-Jun-2020
Audience: Thoracic oncologists
Purpose: Recommendations to guide decisions in lung cancer treatment during the COVID-19 pandemic.

Brazilian Gastrointestinal Tumours Group
Evidence-based recommendations for gastrointestinal cancers during the COVID-19 pandemic by the Brazilian Gastrointestinal Tumours Group
Date: 22-May-2020
Audience: Gastrointestinal oncologists
Purpose: Evidence-based recommendations to treat and minimise the risk of COVID-19 for cancer patients.

Middle East

Lebanese Society of Hematology and Blood Transfusion
Changing Management of Hematological Malignancies With COVID-19: Statement and Recommendations of the Lebanese Society of Hematology and Blood Transfusion
Date: 15-Mar-2021
Audience: Health professionals
Purpose: Recommendations to manage SARS-Cov-2 infection in the patients with myeloid and lymphoid hematological malignancies.

International

International Late Effects of Childhood Cancer Guideline Harmonization Group
Guidance regarding COVID‐19 for survivors of childhood, adolescent, and young adult cancer: A statement from the International Late Effects of Childhood Cancer Guideline Harmonization Group
Date: 23-Sep-2020
Audience: Health professionals
Purpose: Guidance for healthcare practitioners and childhood, adolescent and young adult cancer survivors during the COVID-19 pandemic.

International Society of Geriatric Oncology (SIOG)
Adapting care for older cancer patients during the COVID-19 pandemic: Recommendations from the International Society of Geriatric Oncology (SIOG) COVID-19 Working Group
Date: 16-Jul-2020
Audience: Geriatric oncologists
Purpose: Consensus recommendations on the implications of the COVID-19 pandemic on several aspects of cancer care in this age group including geriatric assessment (GA), surgery, radiotherapy, systemic treatment, palliative care and research.

International Society for Pediatric Oncology (SIOP), Children's Oncology Group (COG), St Jude Global program, and Childhood Cancer International
A rapid global response for children with cancer from SIOP, COG, SIOP‐E, SIOP‐PODC, IPSO, PROS, CCI, and St Jude Global
Date: 13-May-2020
Audience: Paediatric oncology service providers
Purpose: Guidance on diagnostic and treatment protocols for children with cancer during the COVID-19 pandemic.